Elizabethkingia Infections in Humans: From Genomics to Clinics

Meiho University Institutional Repository > 健康暨護理學院 > 生物科技系 > 期刊論文 > Item 987654321/3849

請使用永久網址來引用或連結此文件: http://ir.meiho.edu.tw/ir/handle/987654321/3849

題名:	Elizabethkingia Infections in Humans: From Genomics to Clinics
作者:	Jiun-Nong Lin;Chung-Hsu Lai;Chih-Hui Yang;Yi-Han Huang
貢獻者:	健康暨護理學院
日期:	2019-08
上傳時間:	2020-05-19T06:30:32Z (UTC)
摘要:	The genus Elizabethkingia has recently emerged as a cause of life-threatening infections in humans, particularly in immunocompromised patients. Several new species in the genus Elizabethkingia have been proposed in the last decade. Numerous studies have indicated that Elizabethkingia anophelis, rather than Elizabethkingia meningoseptica, is the most prevalent pathogen in this genus. Matrix-assisted laser desorption/ionization–time of flight mass spectrometry systems with an extended spectrum database could reliably identify E. anophelis and E. meningoseptica, but they are unable to distinguish the remaining species. Precise species identification relies on molecular techniques, such as housekeeping gene sequencing and whole-genome sequencing. These microorganisms are usually susceptible to minocycline but resistant to most -lactams, -lactam/-lactam inhibitors, carbapenems, and aminoglycosides. They often exhibit variable susceptibility to piperacillin, piperacillin-tazobactam, fluoroquinolones, and trimethoprim-sulfamethoxazole. Accordingly, treatment should be guided by antimicrobial susceptibility testing. Target gene mutations are markedly associated with fluoroquinolone resistance. Knowledge on the genomic characteristics provides valuable insights into in these emerging pathogens.
顯示於類別:	[生物科技系] 期刊論文

文件中的檔案:

檔案	描述	大小	格式	瀏覽次數
Elizabethkingia Infections in Humans.pdf		592Kb	Adobe PDF	0	檢視/開啟

檢視Licence

在MUIR中所有的資料項目都受到原著作權保護.

資料載入中.....